SHELTON CAPITAL MANAGEMENT - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 164 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.

Quarter-by-quarter ownership
SHELTON CAPITAL MANAGEMENT ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$3,721,000
+5.3%
66,500
-2.6%
0.18%
+11.3%
Q2 2022$3,535,000
-28.8%
68,3000.0%0.16%
-13.1%
Q1 2022$4,963,000
-38.5%
68,3000.0%0.18%
-36.0%
Q4 2021$8,076,000
-11.9%
68,3000.0%0.29%
-20.1%
Q3 2021$9,162,000
-17.1%
68,3000.0%0.36%
-14.1%
Q2 2021$11,058,000
+101.8%
68,3000.0%0.42%
+118.3%
Q1 2021$5,481,000
+47.5%
68,3000.0%0.19%
+14.4%
Q4 2020$3,716,000
+173.6%
68,3000.0%0.17%
+198.2%
Q3 2020$1,358,000
-5.4%
68,3000.0%0.06%
-29.1%
Q2 2020$1,436,000
+72.0%
68,3000.0%0.08%
+29.5%
Q1 2020$835,000
+11.2%
68,300
+33.4%
0.06%
+45.2%
Q4 2019$751,000
+41.7%
51,200
+29.0%
0.04%
+35.5%
Q3 2019$530,000
+31.2%
39,700
+60.7%
0.03%
+34.8%
Q2 2019$404,000
-96.9%
24,700
+11026.1%
0.02%
-54.9%
Q1 2019$13,000,000
+7244.6%
222
-98.3%
0.05%
+325.0%
Q4 2018$177,000
-52.4%
13,0000.0%0.01%
-42.9%
Q3 2018$372,000
+4.5%
13,0000.0%0.02%
-4.5%
Q2 2018$356,00013,0000.02%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,615,321$23,697,00041.29%
ARK Investment Management 8,741,432$128,237,0003.23%
Nikko Asset Management Americas, Inc. 7,178,520$105,309,0001.66%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$1,635,0000.86%
Elmwood Wealth Management, Inc. 64,204$942,0000.82%
361 CAPITAL LLC 94,772$1,390,0000.38%
Artal Group S.A. 199,700$2,930,0000.11%
StoneX Group Inc. 14,982$220,0000.09%
Sumitomo Mitsui Trust Holdings, Inc. 7,178,520$105,309,0000.08%
PDT Partners, LLC 85,517$1,255,0000.08%
View complete list of INTELLIA THERAPEUTICS INC shareholders